Literature DB >> 11899119

Stage-specific incidence of breast cancer before the beginning of organized screening programs in Italy.

Eva Buiatti1, Alessandro Barchielli, Simone Bartolacci, Lauro Bucchi, Lisi Vincenzo De, Massimo Federico, Stefano Ferretti, Eugenio Paci, Marcello Vettorazzi, Roberto Zanetti.   

Abstract

OBJECTIVE: To measure stage-specific geographic and time variability of breast cancer in seven Italian areas before the onset of organized screening programs.
METHODS: All invasive cancers (8689 cases) arising in women aged 40-79 years during the pre-screening period 1985-1997, were considered. Multiple Poisson regression analysis was performed.
RESULTS: About 39% of the cases were classified as "early," 52% as "advanced," and 9% as "unspecified" stage. Age-adjusted incidence rates showed a significant geographic variation for early but not for advanced cancers (range: 58-103 cases/100,000 and 104-125 cases/100,000, respectively). The result was confirmed in the multiple regression analysis after adjustment for year of diagnosis and age. Early breast cancer risk adjusted for age and registry showed a significant increase over time (+3.9% per year for all ages, and +6.2% per year for age category 50-79). In contrast, a decreasing time trend was observed for advanced cancer of 3 cm or over in women aged less than 60.
CONCLUSIONS: In our study, early breast cancer incidence varied both by geographic area and time before the commencement of screening. The differences in early-stage incidence may well be related to differences in availability of "spontaneous" mammography. Late-stage incidence decreased over time in younger women and for very advanced cases, but not in the older ones, nor for cancers less than 3 cm. Early detection outside organized screening was only partially efficient in reducing advanced breast cancer incidence. The trend of incidence of advanced disease, as previously proposed, is confirmed to be a valid early indicator of effectiveness of screening.

Entities:  

Mesh:

Year:  2002        PMID: 11899119     DOI: 10.1023/a:1013950821981

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  4 in total

1.  Incidence, detection, and tumour stage of breast cancer in a cohort of Italian women with negative screening mammography report recommending early (short-interval) rescreen.

Authors:  Alessandra Ravaioli; Flavia Foca; Americo Colamartini; Fabio Falcini; Carlo Naldoni; Alba C Finarelli; Priscilla Sassoli de Bianchi; Lauro Bucchi
Journal:  BMC Med       Date:  2010-02-01       Impact factor: 8.775

2.  Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study.

Authors:  Matteo Clavarezza; Giorgio Mustacchi; Andrea Casadei Gardini; Lucia Del Mastro; Andrea De Matteis; Ferdinando Riccardi; Vincenzo Adamo; Enrico Aitini; Domenico Amoroso; Paolo Marchetti; Stefania Gori; Francesco Carrozza; Evaristo Maiello; Francesco Giotta; Davide Dondi; Marco Venturini
Journal:  BMC Cancer       Date:  2012-06-06       Impact factor: 4.430

3.  Screen-detected vs clinical breast cancer: the advantage in the relative risk of lymph node metastases decreases with increasing tumour size.

Authors:  L Bucchi; A Barchielli; A Ravaioli; M Federico; V De Lisi; S Ferretti; E Paci; M Vettorazzi; S Patriarca; A Frigerio; E Buiatti
Journal:  Br J Cancer       Date:  2005-01-17       Impact factor: 7.640

4.  Breast Cancer Diagnosis in Coronavirus-Era: Alert From Italy.

Authors:  Gianluca Vanni; Marco Pellicciaro; Marco Materazzo; Leonardo Palombi; Oreste Claudio Buonomo
Journal:  Front Oncol       Date:  2020-05-22       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.